This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3lc5
From Proteopedia
Contents |
Selective Benzothiophine Inhibitors of Factor IXa
Template:ABSTRACT PUBMED 20121197
About this Structure
3lc5 is a 2 chain structure of Factor IX with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Wang S, Beck R, Burd A, Blench T, Marlin F, Ayele T, Buxton S, Dagostin C, Malic M, Joshi R, Barry J, Sajad M, Cheung C, Shaikh S, Chahwala S, Chander C, Baumgartner C, Holthoff HP, Murray E, Blackney M, Giddings A. Structure Based Drug Design: Development of Potent and Selective Factor IXa (FIXa) Inhibitors. J Med Chem. 2010 Feb 25;53(4):1473-82. PMID:20121197 doi:10.1021/jm901476x
Categories: Coagulation factor IXa | Homo sapiens | Beck, R. | Wang, S. | Blood coagulation | Cleavage on pair of basic residue | Disease mutation | Disulfide bond | Egf-like domain | Gamma-carboxyglutamic acid | Glycoprotein | Hemophilia | Hydrolase | Hydrolase-hydrolase inhibitor complex | Hydroxylation | Peptidase s1 | Phosphoprotein | Protease | Protein-inhibitor complex | Secreted | Serine protease | Sulfation | Zymogen
